ZKSC1_HUMAN - dbPTM
ZKSC1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ZKSC1_HUMAN
UniProt AC P17029
Protein Name Zinc finger protein with KRAB and SCAN domains 1
Gene Name ZKSCAN1
Organism Homo sapiens (Human).
Sequence Length 563
Subcellular Localization Nucleus .
Protein Description May be involved in transcriptional regulation..
Protein Sequence MMTAESREATGLSPQAAQEKDGIVIVKVEEEDEEDHMWGQDSTLQDTPPPDPEIFRQRFRRFCYQNTFGPREALSRLKELCHQWLRPEINTKEQILELLVLEQFLSILPKELQVWLQEYRPDSGEEAVTLLEDLELDLSGQQVPGQVHGPEMLARGMVPLDPVQESSSFDLHHEATQSHFKHSSRKPRLLQSRALPAAHIPAPPHEGSPRDQAMASALFTADSQAMVKIEDMAVSLILEEWGCQNLARRNLSRDNRQENYGSAFPQGGENRNENEESTSKAETSEDSASRGETTGRSQKEFGEKRDQEGKTGERQQKNPEEKTRKEKRDSGPAIGKDKKTITGERGPREKGKGLGRSFSLSSNFTTPEEVPTGTKSHRCDECGKCFTRSSSLIRHKIIHTGEKPYECSECGKAFSLNSNLVLHQRIHTGEKPHECNECGKAFSHSSNLILHQRIHSGEKPYECNECGKAFSQSSDLTKHQRIHTGEKPYECSECGKAFNRNSYLILHRRIHTREKPYKCTKCGKAFTRSSTLTLHHRIHARERASEYSPASLDAFGAFLKSCV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Phosphorylation--MMTAESREATGLS
--CCCHHHHHHHCCC
32.72-
10PhosphorylationTAESREATGLSPQAA
CHHHHHHHCCCHHHH
33.6230266825
13PhosphorylationSREATGLSPQAAQEK
HHHHHCCCHHHHHHC
19.1329255136
20UbiquitinationSPQAAQEKDGIVIVK
CHHHHHHCCCEEEEE
49.53-
27SumoylationKDGIVIVKVEEEDEE
CCCEEEEECCCCCCC
32.5728112733
42PhosphorylationDHMWGQDSTLQDTPP
CCCCCCCCCCCCCCC
24.1127732954
43PhosphorylationHMWGQDSTLQDTPPP
CCCCCCCCCCCCCCC
36.4127732954
47PhosphorylationQDSTLQDTPPPDPEI
CCCCCCCCCCCCHHH
25.4130576142
166PhosphorylationPLDPVQESSSFDLHH
ECCCCCCCCCCCCCC
17.7528348404
167PhosphorylationLDPVQESSSFDLHHE
CCCCCCCCCCCCCCH
33.9828348404
168PhosphorylationDPVQESSSFDLHHEA
CCCCCCCCCCCCCHH
31.8728348404
178PhosphorylationLHHEATQSHFKHSSR
CCCHHHHHHHCCCCC
26.9128555341
181UbiquitinationEATQSHFKHSSRKPR
HHHHHHHCCCCCCCC
36.83-
181SumoylationEATQSHFKHSSRKPR
HHHHHHHCCCCCCCC
36.8328112733
184PhosphorylationQSHFKHSSRKPRLLQ
HHHHCCCCCCCCHHH
44.00-
208PhosphorylationPAPPHEGSPRDQAMA
CCCCCCCCHHHHHHH
17.4929255136
216PhosphorylationPRDQAMASALFTADS
HHHHHHHHHHHCCCC
16.6624247654
223PhosphorylationSALFTADSQAMVKIE
HHHHCCCCCCCHHHH
19.85-
228SumoylationADSQAMVKIEDMAVS
CCCCCCHHHHHHHHH
27.5628112733
252PhosphorylationNLARRNLSRDNRQEN
HHHHCCCCCCCCHHH
40.9327251275
262PhosphorylationNRQENYGSAFPQGGE
CCHHHCCCCCCCCCC
19.1727251275
279PhosphorylationNENEESTSKAETSED
CCCHHHCCCCCCCHH
38.8628555341
280SumoylationENEESTSKAETSEDS
CCHHHCCCCCCCHHH
50.7828112733
280UbiquitinationENEESTSKAETSEDS
CCHHHCCCCCCCHHH
50.7821906983
280SumoylationENEESTSKAETSEDS
CCHHHCCCCCCCHHH
50.78-
283PhosphorylationESTSKAETSEDSASR
HHCCCCCCCHHHHHC
42.1325850435
284PhosphorylationSTSKAETSEDSASRG
HCCCCCCCHHHHHCC
30.8025850435
287PhosphorylationKAETSEDSASRGETT
CCCCCHHHHHCCCCC
24.8829255136
289PhosphorylationETSEDSASRGETTGR
CCCHHHHHCCCCCCC
44.7829255136
293PhosphorylationDSASRGETTGRSQKE
HHHHCCCCCCCCHHH
37.0629255136
294PhosphorylationSASRGETTGRSQKEF
HHHCCCCCCCCHHHH
26.7129255136
299SumoylationETTGRSQKEFGEKRD
CCCCCCHHHHHHHHC
57.1528112733
304SumoylationSQKEFGEKRDQEGKT
CHHHHHHHHCCCCCC
62.7528112733
310AcetylationEKRDQEGKTGERQQK
HHHCCCCCCCHHHHC
53.2418586575
330PhosphorylationTRKEKRDSGPAIGKD
HHHHHHCCCCCCCCC
51.1930576142
336AcetylationDSGPAIGKDKKTITG
CCCCCCCCCCCCCCC
61.3325953088
339SumoylationPAIGKDKKTITGERG
CCCCCCCCCCCCCCC
56.1228112733
339SumoylationPAIGKDKKTITGERG
CCCCCCCCCCCCCCC
56.12-
357PhosphorylationKGKGLGRSFSLSSNF
CCCCCCCCEECCCCC
19.8625159151
359PhosphorylationKGLGRSFSLSSNFTT
CCCCCCEECCCCCCC
28.7025159151
361PhosphorylationLGRSFSLSSNFTTPE
CCCCEECCCCCCCCC
23.2628348404
362PhosphorylationGRSFSLSSNFTTPEE
CCCEECCCCCCCCCC
41.0528348404
365PhosphorylationFSLSSNFTTPEEVPT
EECCCCCCCCCCCCC
45.7730108239
366PhosphorylationSLSSNFTTPEEVPTG
ECCCCCCCCCCCCCC
25.2725159151
372PhosphorylationTTPEEVPTGTKSHRC
CCCCCCCCCCCCCCC
63.7622199227
374PhosphorylationPEEVPTGTKSHRCDE
CCCCCCCCCCCCCCC
31.6726074081
375UbiquitinationEEVPTGTKSHRCDEC
CCCCCCCCCCCCCCC
45.68-
375SumoylationEEVPTGTKSHRCDEC
CCCCCCCCCCCCCCC
45.6828112733
384UbiquitinationHRCDECGKCFTRSSS
CCCCCCCCCCCCCHH
37.52-
390PhosphorylationGKCFTRSSSLIRHKI
CCCCCCCHHHHCCEE
26.3524719451
391PhosphorylationKCFTRSSSLIRHKII
CCCCCCHHHHCCEEE
29.1224719451
396UbiquitinationSSSLIRHKIIHTGEK
CHHHHCCEEEECCCC
33.24-
400PhosphorylationIRHKIIHTGEKPYEC
HCCEEEECCCCCEEC
36.3129496963
403UbiquitinationKIIHTGEKPYECSEC
EEEECCCCCEECCCC
55.00-
405PhosphorylationIHTGEKPYECSECGK
EECCCCCEECCCCCC
40.41-
408PhosphorylationGEKPYECSECGKAFS
CCCCEECCCCCCEEE
24.7927251275
412SumoylationYECSECGKAFSLNSN
EECCCCCCEEECCCC
58.9028112733
412SumoylationYECSECGKAFSLNSN
EECCCCCCEEECCCC
58.90-
415PhosphorylationSECGKAFSLNSNLVL
CCCCCEEECCCCEEE
31.3428555341
418PhosphorylationGKAFSLNSNLVLHQR
CCEEECCCCEEEEEE
36.5128555341
428PhosphorylationVLHQRIHTGEKPHEC
EEEEEECCCCCCCCC
44.6727282143
440SumoylationHECNECGKAFSHSSN
CCCCCCHHCCCCCCC
58.9028112733
443PhosphorylationNECGKAFSHSSNLIL
CCCHHCCCCCCCEEE
27.5923312004
445PhosphorylationCGKAFSHSSNLILHQ
CHHCCCCCCCEEEEE
21.5223312004
446PhosphorylationGKAFSHSSNLILHQR
HHCCCCCCCEEEEEE
30.1723312004
456PhosphorylationILHQRIHSGEKPYEC
EEEEECCCCCCCEEC
46.4026657352
459UbiquitinationQRIHSGEKPYECNEC
EECCCCCCCEECCCC
57.32-
461PhosphorylationIHSGEKPYECNECGK
CCCCCCCEECCCCHH
44.1523312004
468UbiquitinationYECNECGKAFSQSSD
EECCCCHHHHHCCCC
58.90-
471PhosphorylationNECGKAFSQSSDLTK
CCCHHHHHCCCCCCC
33.7317525332
473PhosphorylationCGKAFSQSSDLTKHQ
CHHHHHCCCCCCCCC
25.3123312004
478SumoylationSQSSDLTKHQRIHTG
HCCCCCCCCCCCCCC
45.0728112733
478UbiquitinationSQSSDLTKHQRIHTG
HCCCCCCCCCCCCCC
45.07-
478SumoylationSQSSDLTKHQRIHTG
HCCCCCCCCCCCCCC
45.07-
484PhosphorylationTKHQRIHTGEKPYEC
CCCCCCCCCCCCCCC
44.6729496963
489PhosphorylationIHTGEKPYECSECGK
CCCCCCCCCCCHHHH
40.41-
492PhosphorylationGEKPYECSECGKAFN
CCCCCCCCHHHHCCC
24.7927251275
496SumoylationYECSECGKAFNRNSY
CCCCHHHHCCCCCCE
62.56-
496UbiquitinationYECSECGKAFNRNSY
CCCCHHHHCCCCCCE
62.56-
496SumoylationYECSECGKAFNRNSY
CCCCHHHHCCCCCCE
62.56-
502PhosphorylationGKAFNRNSYLILHRR
HHCCCCCCEEEEECC
20.3430108239
503PhosphorylationKAFNRNSYLILHRRI
HCCCCCCEEEEECCE
11.0030108239
527PhosphorylationTKCGKAFTRSSTLTL
CCCCCEEECCCCEEH
34.2028555341
529PhosphorylationCGKAFTRSSTLTLHH
CCCEEECCCCEEHHH
25.3123312004
530PhosphorylationGKAFTRSSTLTLHHR
CCEEECCCCEEHHHH
24.9328555341
531PhosphorylationKAFTRSSTLTLHHRI
CEEECCCCEEHHHHH
25.6323312004
533PhosphorylationFTRSSTLTLHHRIHA
EECCCCEEHHHHHHH
24.9223312004
545PhosphorylationIHARERASEYSPASL
HHHHHHHHHCCCHHH
43.2023403867
547PhosphorylationARERASEYSPASLDA
HHHHHHHCCCHHHHH
19.9123403867
548PhosphorylationRERASEYSPASLDAF
HHHHHHCCCHHHHHH
15.2228176443
551PhosphorylationASEYSPASLDAFGAF
HHHCCCHHHHHHHHH
30.1128176443
560UbiquitinationDAFGAFLKSCV----
HHHHHHHHHCC----
35.04-
560SumoylationDAFGAFLKSCV----
HHHHHHHHHCC----
35.0428112733

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ZKSC1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ZKSC1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ZKSC1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049
ZSC32_HUMANZSCAN32physical
25416956

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ZKSC1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13 AND SER-208, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-471, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY.

TOP